Immune reactions after eating gluten in people with celiac disease and healthy volunteers
Looks at immune responses after eating gluten powder in celiac disease and healthy controls.
Key facts
- Who runs it
- Boston Children's Hospital
- Where
- Aurora and Boston, United StatesSee the 2 sites
- Trial code
- Registry title
- Immune Responses to Gluten
- Status
- Enrolling by invitation
- People taking part
- 400 people, planned
- Started
- 15 Jan 2023
- Expected to end
- 30 Sept 2029
- Type of study
- Interventional, 2 groups
- Treatments tested
- Gluten Powder
- Record updated
- 11 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with celiac disease and healthy people without it. Everyone eats one dose of gluten powder so researchers can study immune responses.
- Age
- 2 Years to 101 Years
- Sex
- All sexes can join.
- Disease stage
- People in the celiac disease group need a diagnosis confirmed by blood tests (serology) and/or a tissue sample (histology). Healthy people without celiac disease can also join.
- Earlier treatment
- Everyone must have been on a gluten-free diet for 4 weeks or more. Everyone must be willing to eat gluten for the research.
Main reasons for not taking part
- Pregnancy
- Wheat allergy
- Type 1 diabetes
- BMI z-score < -2 (very low weight for age)
- More than mild symptoms after gluten exposure while on a gluten-free diet
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- On a gluten-free diet for ≥ 4 weeks
- Willing to consume gluten for research
- For the celiac disease arm, diagnosis confirmed by serology and/or histology
Who cannot take part
- Wheat allergy
- Type 1 diabetes
- History of more than minimal symptoms following gluten exposure on a gluten-free diet
- Comorbid condition that in the opinion of the investigator would interfere with study participation or would confound study results
- Pregnancy
- BMI z-score < -2
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 2 and 101 years old?
Where in United States
- Children's Hospital ColoradoAurora, United StatesEnrolling by invitation
- Boston Children's HospitalBoston, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This is a study of immune responses after eating gluten powder in people with celiac disease and healthy controls.
The 2 groups in the trial
- Celiac DiseaseTreatment being tested
Individuals with a confirmed diagnosis of celiac disease based on serology and/or histology
Treatment: Gluten Powder
- Healthy ControlsTreatment being tested
Individuals without a diagnosis of celiac disease
Treatment: Gluten Powder
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Changes in Serum IL-2 Levels Following a Single Oral Dose of Gluten
- Plain-language title
- Immune reactions after eating gluten in people with celiac disease and healthy volunteersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05209568, who can take part
- Record updated
- 11 September 2026